Alphatec Holdings

ATEC

Market cap $1.73B

Craig Hunsaker sold 116,367 shares across two open-market transactions on March 6 and March 9, 2026, for a total of ~$1.44 million at a weighted average price of $12.38 per share. This activity represented 6.32% of Hunsaker's direct holdings prior to the transaction, reducing direct ownership from approximately 1.84 million to 1.73 million shares.

The CFO of Alphatec Holdings reported selling 79,789 shares of the company on March 13, 2026, generating a transaction value of approximately $986,000. This disposition represented 11.7% of John Todd Koning's direct common stock holdings, reducing his direct ownership to 600,721 shares after the trade.

Alphatec Holdings, Inc. (ATEC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Over the course of 2025, Alphatec Holdings or "ATEC" has continued to outperform sales expectations and taken additional share in the $8 billion U.S. spinal disorder treatment market. In addition, the company has delivered vastly improved profitability and cash flow. While moderately lower growth expectations for 2026 appear to have impacted the stock price in recent weeks, I would consider the selloff a buying opportunity.

Alphatec (ATEC) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.23 per share a year ago.

Alphatec Holdings, Inc. (ATEC) Q4 2025 Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2025, and business highlights. Fourth Quarter and Full-Year 2025 Financial Results Quarter Ended December 31, 2025 Year Ended December 31, 2025 Total revenue $213 million $764 million GAAP gross margin 70% 70% Non-GAAP gross margin 71% 7.

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Craig E. Hunsaker, EVP, People & Culture at Alphatec Holdings, sold 32,584 shares for a transaction value of $679,050.56 at $20.84 per share on Dec. 10, 2025. The sale represented 2.53% of Hunsaker's direct holdings, reducing his stake from 1,289,142 to 1,256,558 shares.

Alphatec Holdings, Inc. (ATEC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript